[Exogenous lipoid pneumonia associated with pulmonary and hepatic sarcoidosis]

J Margery1, C Martin, C Epaud

  • 1Unité Fonctionnelle d'Oncologie Thoracique, Hôpital Tenon, Paris, France. j.margery@free.fr

Abstract

Insights

Exogenous lipoid pneumonia (ELP) can present with systemic sarcoidosis. This case highlights a patient with ELP and hepatic sarcoidosis, successfully treated with corticosteroids.

Area of Science:

  • Pulmonology
  • Gastroenterology
  • Immunology

Background:

  • Exogenous lipoid pneumonia (ELP) diagnosis requires a history of liquid paraffin ingestion and specific findings in bronchial lavage.
  • Radiological abnormalities beyond typical ELP may indicate co-existing conditions like infection or cancer.

Observation:

  • A 50-year-old woman presented with alveolar shadowing, mediastinal lymphadenopathy, pleural effusion, and hepatic nodules.
  • Initial diagnosis of ELP did not fully explain the extensive radiological findings.
  • Thoracotomy and biopsies were performed for definitive diagnosis.

Findings:

  • Histological examination ruled out malignancy and mycobacterial disease.
  • Biopsies revealed a granulomatous foreign body reaction consistent with pulmonary and hepatic sarcoidosis alongside ELP.
  • Treatment with oral corticosteroids led to resolution of mediastinal lymphadenopathy, pleural effusion, and hepatic nodules.

Implications:

  • This case demonstrates a rare co-occurrence of exogenous lipoid pneumonia and systemic sarcoidosis with hepatic involvement.
  • Corticosteroid therapy can be effective in managing the systemic manifestations of this combined condition.
  • Highlights the importance of considering systemic diseases when radiological findings are atypical for ELP.

Related Concept Videos

Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...